Mico BioMed Reports Operating Loss of 19.3 Billion KRW Last Year... Continued Deficit
Mico Biomed announced that its operating loss last year was 19.3 billion KRW, continuing its deficit. The net loss for the period was 25.7 billion KRW.
Hot Picks Today
"Following President Lee's Advice, Invested Entire Assets in Funds"...Sangwook Kim's Wealth Jumps by 1.2 Billion Won in 4 Months
- "Enjoy Unlimited Sirloin Steak and 150 Dishes"—Why the Largest U.S. Buffet Chain Stays Profitable
- Seoul National University Elites Caught in KRW 20 Billion Stock Manipulation Cartel (Comprehensive)
- "One in Three Unsuitable for Marriage": 72-Year-Old Professor's Diagnosis Sparks Fierce Debate Among Chinese Netizens
The company explained that sales in the molecular diagnostics sector (PCR devices and reagents, etc.) and the immunodiagnostics sector (RDT kits, etc.) decreased due to the transition to the COVID-19 endemic phase.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
!["Failed Even With Net Assets of 400 Million Won?"... Six Criteria That Define 'The Real Middle Class' [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026092809144741876_1790554486.jpg)
